Safe and effective iron supplementation in malaria endemic areas

Not Applicable

Completed

• Conditions: Anemia, malaria and geohelminths; Haematological Disorders; Iron deficiency anaemia

• Registration Number: ISRCTN83091970
• Lead Sponsor: utricia Research Foundation (Netherlands)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2012-05-16
• Last Update Posted: 20 February 2017

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 350

Inclusion Criteria

1. Those who have given informed consent
2. Both males and females
3. Aged between 6-18 years old
4. Malarial parasitemia negative by microscopy
5. Hemoglobin (Hb) > 8 g/dl
6. Hb < 11.5 g/dL for children aged <7 years
7. Hb <12 g/dL for girls aged >= 7 years
8. Hb <13 g/dL for boys aged >=7 years

Exclusion Criteria

Clinical symptoms indicating malaria or any severe underlying condition

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Microscopic and submicroscopic incidence of malaria

Secondary Outcome Measures

Name	Time	Method
1. Changes in hemoglobin levels<br>2. Iron parameters (ferritin, sTFR)<br>3. Endothelial cells markers (ICAM-1 and Vwf)<br>4. C-reactive protein (CRP)